LONDON (Reuters) - About 1,500 of the initial volunteers in a late-stage clinical trial of the Oxford/AstraZeneca COVID-19 vaccine were given the wrong dose, but weren't informed that a mistake had ...
Since the coronavirus enters the body through the nose, researchers have figured a nasal spray may be one way to defend against its spread. But developing an effective point-of-entry vaccine can be ...
The University of Oxford received 143 million pounds ($176 million) in royalties from its COVID-19 vaccine in the past academic year—more than all British universities earned from intellectual ...
Breakthroughs, discoveries, and DIY tips sent every weekday. Terms of Service and Privacy Policy. Researchers at Oxford announced today that a nasal spray version of ...
A June 24 Facebook post (direct link, archive link) shows an image of COVID-19 vaccine vials. “Oxford University: Myocarditis and Pericarditis Only Appear After COVID Vaccination, Not After COVID ...
Scientists say H3N1 flu strain seems to be worse for the elderly as they launch a trial to prove which drugs work for patients hospitalised with severe inluenza ...
According to the COVID-19 Weekly Epidemiological Update published on 15 March 2022 by the World Health Organization, “as of 13 March 2022, over 455 million confirmed cases and over 6 million deaths ...
The coronavirus disease (COVID-19) pandemic led to severe infections and deaths of millions of people worldwide. Initially, non-pharmaceutical measures were used extensively to reduce illness and ...
New research published in The Lancet Psychiatry has offered the most comprehensive look at the long-term neurological effects of COVID-19 published to date, tracking more than one million people for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback